US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Articles published by OS Therapies Inc.

News headline image
OS Therapies Announces Warrant Exercise Inducement & Exchange Offer
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
News headline image
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
News headline image
OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
From OS Therapies Inc.
Via Business Wire
Tickers OSTX
News headline image
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
From OS Therapies Inc.
Via Business Wire
Tickers OSTX